Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02440685
Title A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Asana BioSciences
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Tempe Arizona 85284 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
Winship Cancer Institute - Emory Atlanta Georgia 30322 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
START - Midwest Grand Rapids Michigan 49546 United States Details
University of Mississippi Medical Center Jackson Mississippi 39216 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Hospital Universitario Austral Buenos Aires Derqui, Pilar 1629 Argentina Details
Instituto Alexander Fleming Ciudad Autonoma de Buenos Aires 1426 Argentina Details
*Shaded cells indicate that there was no data available from for the field